Share on StockTwits

Soligenix (NASDAQ:SNGX) issued its quarterly earnings data on Tuesday. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04, American Banking News reports.

Shares of Soligenix (NASDAQ:SNGX) opened at 2.03 on Tuesday. Soligenix has a 52 week low of $1.40 and a 52 week high of $2.50. The stock’s 50-day moving average is $2.07 and its 200-day moving average is $2.09. The company’s market cap is $40.5 million.

Soligenix, Inc is a late-stage research and development biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatment and serious gastrointestinal diseases where there remains an unmet medical need, as well as developing biodefense vaccines and therapeutics.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.